AI-generated summary
The authors randomized 220 head and neck cancer patients receiving chemoradiotherapy to low-level laser therapy or placebo and used patient-reported questionnaires to assess oral mucositis and quality of life. They report that the laser group had significantly lower mucositis and quality-of-life scores, along with reduced severe mucositis, opioid use and parenteral nutrition needs.
- Participants
- 220
- Who or what was studied
- Head and neck cancer patients scheduled for chemoradiotherapy with weekly cisplatin and radiation
- Limits stated in the abstract
- The abstract reports a triple-blinded randomized design but does not describe limitations, and the study is a single trial with a placebo control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Total energy
- 3.0 J, 40 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Oral mucositis, Randomized controlled trial, Statistical significance, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.